Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ahh what - lady cougar vs Lee Klarich wired - and that total PNAW silence -definitely unsafe security breach.
1 for 5 that reduces current 280M share to 56M and then based on SEC filing earlier in the year they will add ~200M + new shares. and that is sad, major dilution, shortly current shares will be worth less than 30c. Everyone trying AEVA lidar but no one made serious commitment. productivity low, burn rate to high. curious about insiders holdings - are they RS resistant or be treated like other investors
it is irrelevant whether ER beat or miss, every buy now is the best opportunity, the difference in the price won't make a big difference in a year and beyond. Little knowledge of Quantum physics, RGTI patent portfolio https://patents.justia.com/assignee/rigetti-co-llc
and little understanding of what coming out of RGTI kitchen should be the investment guide for little people on future of regenerative AI Robotics space science and everything in between.
what a mystified WS head fake, confused, drunken, stage 8 dementia carrying fox howlers can't read or interpret ER even on a early afternoon Thursday
ha roman after 26M in pocket becoming chairman of 3M board, obviously smelling rotten fish - after converting this from an innovative to xnovative company - what next
Total Cash
right now RGTI shares available at less than tenth of pocket change even for a poor investor. They need to go back to ipo price and then only people will start paying the lower end of day to day true value
2.36 - 1.90 that was some erratic impatience move. let it be step by step to the future - let everyone come to the door including nvda
not really -after in depth DD: believe the PANW crush not real - it is was synthesized scar on PANW by oligarchy few - and their next action will run it over 400+ in a hurry - so stay prepared with eyes peeled to identify the time and take action when oligarchy take next PANW market action - it will sprint hard no doubt. they might do the same to some of the other companies next.
looking into whisper if any over there in wallstreetbets
must be epic security malfunction
did ROKU effectively close that massive early NOV. gap if not then touching it could be nothing but another round of sharp electrocution.
This prediction still stands. RGTI is James Webb of Quantum computing and more.
funny Chinese legacy company - modest no exuberant. Obviously they control earning number, control stock price, they control ... they control their companies from backyard roasting oven..
ahh
no kidding - AEVA!!!!!!???????
ONCY earning release tomorrow - Guess it is time for them to talk more on FDA approval, launch time line and the players
"PANW reported 2nd quarter 2024 earnings of USD 1.46 per share on 2/20/24.This beat the consensus of USD 1.30 by USD 0.16 of the 38 analysts covering this company" - but even on a day like today (everything GREEN) its SP melting like a ice block placed on 400degree oven. is this a opportunity or the trend to continue.......
is this PANW a unicorn or pink sheet or what? didn't they released positive ER ? Why in falling knife mode, wow looks like over $80 down even after some early recovery. Bet even pink sheet unicorn companies do not exhibit such drama. what is the real scoop here - is it by any chance another pre squeeze game stop like case? or it is a political drama?
Patents Assigned to Oncolytics Biotech, Inc. till 2020, 2021-24 newly filed list not yet public
https://patents.justia.com/assignee/oncolytics-biotech-inc
2024 Outlook: Dr. Coffey: Looking ahead to 2024, we expect to initiate the first Phase 3 study for pelareorep in pancreatic cancer. The transition to a late-stage biopharmaceutical company will mark an important inflection point for investors, clinical collaborators and potential partners by providing a line of sight towards the path to regulatory approval and achieving our mission of developing pelareorep as an immunotherapeutic agent for cancer. We are excited to launch a new Phase 1/2 pancreatic cancer study investigating, for the first time, pelareorep in combination with modified FOLFIRINOX (mFOLFIRINOX). Finally, our discussions with regulators on a pivotal Phase 3 trial have been productive to date, and we expect to provide guidance on the registration path for metastatic breast cancer in the first half of 2024. We look forward to updating our stakeholders on our progress as the year unfolds."
Nvidia holding nearly 3.5 million shares in TuSimple Holdings (TSPH) - why?
are they buying TSPH TRUCKS?
QUAKE in spite of perfect results - must be power of WS manipulators from OUS
EARTHQUAKE
this could be $20 to $80 in a single day
there drug showing game changing result in pancreatic cancer in clinical trials - that is why so many big company now lined up behind
ACLS --> ALGM <-- LSCC
scratching a little, hoping one day this year will make 5k to 50k and more
claustrophobic
Long and strong Aeva holders enjoys life long tax write off - no worry for capital gain here.
ACLS ALGM
is some group or competitor going rogue against this company - guess they want them to fall under their knee. reached all time low even after producing continued earning beats.
man no downgrade - seems they are going to run it up -
APLD had Total Debt 103.97M and that is now reduced to $42.8 million. Total Revenue: $42.2 million, that is a 242% increase from the second quarter of 2023. Net Loss: $10.5 million, is a major improvement from a net loss of $26.8 million in the 2nd QQ of 2023.
Ended the quarter with $34.6 million in cash and equivalents.
seems market over reacted without considering the detail. of the 13M dump today, mostly retail and day trader. no institutional dump.
31.72% % of Shares Held by All Insider
54.30% % of Shares Held by Institutions
79.53% % of Float Held by Institutions
conclusion APLD doing good to better and - of course buying back is a better option during the next week or two volatility.
for now sold all apld with some profit.
strangely no downgrade - may show up latter
so low premarket volume suggests forced sell at lower SP, the premarket SP down likely to reverse in regular session
Consolidated Last Sale $6.11 -1.38 (-18.42%)
Pre-Market Volume 541,606
yap better than expected BTE Q-result is the key and market knows that and working accordingly, They turning and turning the spring and forming super coil, Now it will break below 5s or go-up beyond mesosphere. today is the last day for cheapies.
If they deliver BTE Q-result on the 16th then $25 before next Q- earning release - not unexpected. this may turn into a beast mode at some point starting next week. expect to see it crossing $100 by Dec 2024
Rigetti Superconducting & Superconducting transmon 2018 - 2022
RIGITTI quantum circuit and quantum logic gate-based model of computing.
Agave
Acorn
Aspen-1, -4, -7, -8,--9, -10, -11
Aspen-M-1, M-2, M-3
Whenever possible buying this at and below $10, in a year this going to be $100+, Qly rev. growth 400%+, every AI crypto block chain and everything in between need storage and APLD sitting at the center of that revolution and growing at reasonably fast speed.
What changed for such reaction today
nice MARA is up while BTC bigtime down.
Rigetti has portfolio of 165 patents - any chance they are coming out of dungeon dwelling this year.
from day one of inception till to date AEVA never gave real news -